Janssen and EFSD announce that they will renew their partnership, first announced in 2010, to support research into the role of the kidney in diabetes in the coming year. This partnership continues the collaboration between the EFSD and Johnson & Johnson companies,with the two organisationsjointly contributing up to €400,000 to fund the research.
Also announced is the partnership between EFSD and Janssen for the Rising Stars Symposium which aims to identify promising and innovative young researchers in Europe. Four selected candidates will have the opportunity to present an overview of their past and ongoing research activities during a multidisciplinary research symposium at the 2012 European Association for the Study of Diabetes (EASD) annual meeting. Each candidate will also receive a commemorative diploma and a research fellowship of €30,000 payable to the applicant’s institution.
“We are delighted that Janssen will again partner with the EFSD in 2011-2012 to support research into the role of the kidney in diabetes. But also new to this year, we are proud to join forces with Janssen for the Rising Stars symposium and fellowship which will identify and provide support to emerging young researchers”, commented Professor Dr. Ulf Smith, Gothenburg, President of EASD/EFSD.
“We are committed to increasing the understanding of diabetes through our own research and development programme and through sponsorship of research projects such as the EFSD/Janssen Programme for the Study of the Role of the Kidney in Diabetes and the Rising Stars Symposium fellowship. Through these programmes, we hope to stimulate the advancement of knowledge about diabetes that could contribute to the development of new treatment approaches to manage the condition more effectively,” commented Dr Brian Woodfall, Janssen, Vice – President EMEA Medical Affairs. The winner of the 2010-2011 research grant for the EFSD/Janssen Programme for the Study of the Role of the Kidney in Diabetes has been awarded to Dr Paul Squires, University of Warwick, UK, to support his work in diabetic nephropathy.